Assignee
JIVA PHARMA INC
US·8 granted patents·3 pending applications·6 citations·filing 2012–2020
Top patents by PatentIndex Score
11 records- 0186US10125078B1NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulatorsJIVA PHARMA INC·Filed 2016·Granted Nov 13, 2018·2 cites·14 claims
- 0284US9364465B2Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetesJIVA PHARMA INC·Filed 2014·Granted Jun 14, 2016·3 cites·16 claims
- 0368US9808497B2Formulations of concentrated prunes and prebiotics as laxatives and dietary supplementsJIVA PHARMA INC·Filed 2012·Granted Nov 7, 2017·1 cites·1 claims
- 0465US10646477B15-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agentsJIVA PHARMA INC·Filed 2018·Granted May 12, 2020·0 cites·8 claims
- 0564US11202774B25-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agentsJIVA PHARMA INC·Filed 2020·Granted Dec 21, 2021·0 cites·13 claims
- 0664US9815777B2Metformin salts to treat Type2 diabetesJIVA PHARMA INC·Filed 2014·Granted Nov 14, 2017·0 cites·7 claims
- 0759US2017327455A1Omefibrates for Treating Dyslipidemia and Cardiovascular DiseaseJIVA PHARMA INC·Filed 2017·Application pending·0 cites
- 0853US2015344402A1Omefibrates for Treating Dyslipidemia and Cardiovascular DiseaseJIVA PHARMA INC·Filed 2015·Application pending·0 cites
- 0953US2015374660A1Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and UsesJIVA PHARMA INC·Filed 2014·Application pending·0 cites
- 1045US9688613B2Omegabalins, GABA derivatives of omega-3 polyunsaturated acids, their formulations and methods of useJIVA PHARMA INC·Filed 2016·Granted Jun 27, 2017·0 cites·12 claims
- 1137US9540307B2Statins of omega-3 polyunsaturated acids for treating hypercholesterolemiaJIVA PHARMA INC·Filed 2015·Granted Jan 10, 2017·0 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →